AYALA PHARMACEUTICALS, INC.: cashflow_financing

Value{"amount": -161378, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2016-11-01 – 2017-04-30
Statussuperseded
EntityAYALA PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001493152-17-006268 · Open the official SEC filing →
Retrieved: 2026-08-19T11:01:28.181425+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001100397/cashflow-financing/2017-04-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/7223ce4a-d0a4-47f2-b6de-6f0c4bd629ab

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies